Chronic Kidney Disease and Associated Factors Among HIV Infected Patients Taking Tenofovir Disoproxil Fumarate Based Regimen in Ethiopia: A Hospital-Based Cross-Sectional Study

References

• USAIDS. Fact sheet-latest statistics on the status of the AIDS epidemic. 2020.
   Google Scholar
• Kibret GD, Ferede A, Leshargie CT, Wagnew F, Ketema DB, Alebel A. Trends and spatial distributions of HIV prevalence in Ethiopia. Infect Dis Poverty. 2019;8(1):90. doi:10.1186/s40249-019-0594-9
   PubMed Web of Science ®Google Scholar
• Ekrikpo UE, Kengne AP, Bello AK, et al. Chronic kidney disease in the global adult HIV-infected population: a systematic review and meta-analysis. PLoS One. 2018;13(4):e0195443. doi:10.1371/journal.pone.0195443
   PubMed Web of Science ®Google Scholar
• World Health Organization. Policy brief: update of recommendations on first-and second-line antiretroviral regimens. World Health Organization; 2019.
   Google Scholar
• Mocroft A, Lundgren JD, Ross M, et al. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study. Lancet HIV. 2016;3(1):e23–32. doi:10.1016/S2352-3018(15)00211-8
   PubMed Web of Science ®Google Scholar
• Cuzin L, Pugliese P, Allavena C, et al. Antiretroviral therapy as a risk factor for chronic kidney disease: results from traditional regression modeling and causal approach in a large observational study. PLoS One. 2017;12(12):e0187517. doi:10.1371/journal.pone.0187517
   PubMed Web of Science ®Google Scholar
• Zachor H, Machekano R, Estrella MM, et al. Incidence of stage 3 chronic kidney disease and progression on tenofovir-based antiretroviral therapy regimens: a cohort study in HIV-infected adults in Cape Town, South Africa. AIDS. 2016;30(8):1221. doi:10.1097/QAD.0000000000001041
   Web of Science ®Google Scholar
• Suzuki S, Nishijima T, Kawasaki Y, et al. Effect of tenofovir disoproxil fumarate on incidence of chronic kidney disease and rate of estimated glomerular filtration rate decrement in HIV-1–infected treatment-naïve Asian patients: results from 12-year observational cohort. AIDS Patient Care STDS. 2017;31(3):105–112. doi:10.1089/apc.2016.0286
   PubMed Web of Science ®Google Scholar
• Nishijima T, Kawasaki Y, Mutoh Y, et al. Prevalence and factors associated with chronic kidney disease and end-stage renal disease in HIV-1-infected Asian patients in Tokyo. Sci Rep. 2017;7(1):1–8. doi:10.1038/s41598-017-15214-x
   Web of Science ®Google Scholar
• Yazie TS, Orjino TA, Degu WA. Reduced kidney function in tenofovir disoproxil fumarate based regimen and associated factors: a hospital based prospective observational study in Ethiopian patients. Int J Nephrol. 2019;2019:1–9. doi:10.1155/2019/9172607
   Web of Science ®Google Scholar
• Sutton SS, Magagnoli J, Hardin JW, et al. Association of tenofovir disoproxil fumarate exposure with chronic kidney disease and osteoporotic fracture in US veterans with HIV. Curr Med Res Opin. 2020;36(10):1635–1642. doi:10.1080/03007995.2020.1816538
   PubMed Web of Science ®Google Scholar
• Hoang CQ, Nguyen HD, Vu HQ, et al. Determinants of risk factors for renal impairment among HIV-infected patients treated with tenofovir disoproxil fumarate-based antiretroviral regimen in Southern Vietnam. Biomed Res Int. 2020;2020.
   Web of Science ®Google Scholar
• Ahmed E, Diro E, Hailu W, Muhie OA. Assessment of renal dysfunction and associated factors among patients on tenofovir based antiretroviral treatment at Gondar University Hospital, North West Ethiopia: retrospective institution based cross sectional study. J AIDS HIV Res. 2020;12(2):34–44. doi:10.5897/JAHR2019.0498
   Google Scholar
• Alfano G, Guaraldi G, Fontana F, Bellasi A, Cappelli G. Therapeutic management of HIV-infected patients with chronic kidney disease. J Nephrol. 2020;4:1–5.
   Google Scholar
• Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg DR. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials. 2004;5(2):74–79. doi:10.1310/JFXH-G3X2-EYM6-D6UG
   PubMed Web of Science ®Google Scholar
• Kobin AB, Sheth NU. Levels of adherence required for virologic suppression among newer antiretroviral medications. Ann Pharmacother. 2011;45(3):372–379. doi:10.1345/aph.1P587
   PubMed Web of Science ®Google Scholar
• Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005;67(6):2089–2100. doi:10.1111/j.1523-1755.2005.00365.x
   PubMed Web of Science ®Google Scholar
• Ibrahim F, Hamzah L, Jones R, Nitsch D, Sabin C, Post FA. Comparison of CKD-EPI and MDRD to estimate baseline renal function in HIV-positive patients. Nephrol Dial Transplant. 2012;27(6):2291–2297. doi:10.1093/ndt/gfr657
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006
   PubMed Web of Science ®Google Scholar
• Premuzic V, Kruezi E, Berovic M, et al. The association of the decline in glomerular filtration rate with aggressive endometrial cancers. Int Urol Nephrol. 2020;52(1):161–168. doi:10.1007/s11255-019-02324-w
   Web of Science ®Google Scholar
• e Silva V, Costalonga EC, Coelho FO, Caires RA, Burdmann EA. Assessment of kidney function in patients with cancer. Adv Chronic Kidney Dis. 2018;25(1):49–56. doi:10.1053/j.ackd.2017.10.010
   Web of Science ®Google Scholar